Vildagliptin NOBEL 50 mg
Vildagliptin NOBEL 50 mg is a medicine authorised by Swissmedic under authorisation number 68750. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 September 2022 and the authorisation is limited until 25 September 2027. ATC code A10BH02 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 68750 |
|---|---|
| Name | Vildagliptin NOBEL 50 mg |
| Full name | Vildagliptin NOBEL 50 mg, Tabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BH02 |
| First authorisation | 26 September 2022 |
| Authorisation validity | 25 September 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Vildagliptin NOBEL 50 mg, Tabletten | B | 26 September 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A10BH02 | 07.06.2. | B |
| 2 | 112 | Tablette(n) | A10BH02 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Vildagliptin NOBEL 50 mg authorised in Switzerland?
Yes. Vildagliptin NOBEL 50 mg is authorised by Swissmedic under authorisation number 68750, data as of 01 September 2026. The authorisation is limited until 25 September 2027.
Which dispensing category does Vildagliptin NOBEL 50 mg have?
Vildagliptin NOBEL 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Vildagliptin NOBEL 50 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.